{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:11:22Z","timestamp":1782843082759,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,2,5]],"date-time":"2018-02-05T00:00:00Z","timestamp":1517788800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1038\/s41409-018-0111-y","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T15:42:21Z","timestamp":1517326941000},"page":"880-890","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Allogenic peripheral stem cell transplantation from HLA-matched related donors for adult sickle cell disease: remarkable outcomes from a single-center trial"],"prefix":"10.1038","volume":"53","author":[{"given":"H.","family":"Ozdogu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Boga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yeral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Kozanoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gereklioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Aytan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kasar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Asma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Buyukkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Solmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Korur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sariturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,5]]},"reference":[{"key":"111_CR1","first-page":"667","volume-title":"Williams hematology","author":"K Natarajan","year":"2010","unstructured":"Natarajan K, Townes TM, Kutlar A. Disorders of hemoglobin structure: sickle cell anemia and related abnormalities. In: Kaushansky K, Lichtman MA, Beutler E, K\u0131pps TJ, Seligsohn U, Prchal JT, editors. Williams hematology, 8th edn. New York: Mcgraw Hill; 2010. p. 667\u2013700.","edition":"8th edn"},{"key":"111_CR2","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3324\/haematol.2016.153791","volume":"102","author":"P Maitra","year":"2017","unstructured":"Maitra P, Caughey M, Robinson L, Desai PC, Jones S, Nouraie M, et al. Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and Europe. Haematologica. 2017;102:626\u201336.","journal-title":"Haematologica"},{"key":"111_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00277-016-2655-5","volume":"95","author":"PK Karacaoglu","year":"2016","unstructured":"Karacaoglu PK, Asma S, Korur A, Solmaz S, Buyukkurt NT, Gereklioglu C, et al. East Mediterranean region sickle cell disease mortality trial: retrospective multicenter cohort analysis of 735 patients. Ann Hematol. 2016;95:993\u20131000.","journal-title":"Ann Hematol"},{"key":"111_CR4","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0140-6736(00)04132-5","volume":"357","author":"KH Wierenga","year":"2001","unstructured":"Wierenga KH, Hambleton IR, Lewis NA. Survival estimates for patients with homozygous sickle-cell disease in Jamaica: a clinic-based population study. Lancet. 2001;357:680\u20133.","journal-title":"Lancet"},{"key":"111_CR5","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ajh.20904","volume":"82","author":"H Ozdogu","year":"2007","unstructured":"Ozdogu H, Sozer O, Boga C, Kozanoglu L, Maytalman E, Guzey M. Flow cytometric evaluation of circulating endothelial cells: a new protocol for identifying endothelial cells at several stages of differentiation. Am J Hematol. 2007;82:706\u201311.","journal-title":"Am J Hematol"},{"key":"111_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/bjh.12413","volume":"162","author":"S Sheth","year":"2013","unstructured":"Sheth S, Licursi M, Bhatia M. Sickle cell disease: time for a closer look at treatment options? Br J Haematol. 2013;162:455\u201364.","journal-title":"Br J Haematol"},{"key":"111_CR7","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1002\/ajh.24183","volume":"90","author":"AA King","year":"2015","unstructured":"King AA, Kamani N, Bunin N, Sahdev I, Brochstein J, Hayashi RJ, et al. Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies. Am J Hematol. 2015;90:1093\u20138.","journal-title":"Am J Hematol"},{"key":"111_CR8","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/ejh.12082","volume":"90","author":"S Matthes-Martin","year":"2013","unstructured":"Matthes-Martin S, Lawitschka A, Fritsch G, Lion T, Grimm B, Breuer S, et al. Stem cell transplantation after reduced-intensity conditioning for sickle cell disease. Eur J Haematol. 2013;90:308\u201312.","journal-title":"Eur J Haematol"},{"key":"111_CR9","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1182\/blood-2016-10-745711","volume":"129","author":"E Gluckman","year":"2017","unstructured":"Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, et al. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. Blood. 2017;129:1548\u201356.","journal-title":"Blood"},{"key":"111_CR10","first-page":"CD007001","volume":"5","author":"C Oringanje","year":"2016","unstructured":"Oringanje C, Nemecek E, Oniyangi O. Hematopoietic stem cell transplantation for people with sickle cell disease. Cochrane Database Syst Rev. 2016;5:CD007001.","journal-title":"Cochrane Database Syst Rev"},{"key":"111_CR11","doi-asserted-by":"publisher","first-page":"811","DOI":"10.3324\/haematol.2013.099747","volume":"99","author":"E Angelucci","year":"2014","unstructured":"Angelucci E, Matthes-Martin S, Baronciani D, Bernaudin F, Bonanomi S, Cappellini MD, et al. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an International Expert Panel. Haematologica. 2014;99:811\u201320.","journal-title":"Haematologica"},{"key":"111_CR12","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ajh.23683","volume":"89","author":"H Elmariah","year":"2014","unstructured":"Elmariah H, Garrett ME, De Castro LM, Jonassaint JC, Ataga KI, Eckman JR, et al. Factors associated with survival in a contemporary adult sickle cell disease cohort. Am J Hematol. 2014;89:530\u20135.","journal-title":"Am J Hematol"},{"key":"111_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.bbmt.2015.10.017","volume":"22","author":"MC Walters","year":"2016","unstructured":"Walters MC, De Castro LM, Sullivan KM, De Castro LM, Sullivan KM, Krishnamurti L, et al. Indications and results of HLA-identical sibling hematopoietic cell transplantation for sickle cell disease. Biol Blood Marrow Transplant. 2016;22:207\u201311.","journal-title":"Biol Blood Marrow Transplant"},{"key":"111_CR14","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/bmt.2017.34","volume":"52","author":"JR Passweg","year":"2017","unstructured":"Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant. 2017;52:811\u20137.","journal-title":"Bone Marrow Transplant"},{"key":"111_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.hoc.2014.08.014","volume":"28","author":"CD Fitzhugh","year":"2014","unstructured":"Fitzhugh CD, Abraham AA, Tisdale J. Hematopoietic stem cell transplantation for patients with sickle cell disease: progress and future directions. Hematol Oncol Clin North Am. 2014;28:1171\u201385.","journal-title":"Hematol Oncol Clin North Am"},{"key":"111_CR16","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4274\/tjh.2014.0311","volume":"32","author":"H \u00d6zdo\u011fu","year":"2015","unstructured":"\u00d6zdo\u011fu H, Bo\u011fa C. Hematopoietic stem cell transplantation in adult sickle cell disease: problems and solutions. Turk J Hematol. 2015;32:195\u2013205.","journal-title":"Turk J Hematol"},{"key":"111_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/bmt.2015.11","volume":"50","author":"SJ Rotz","year":"2015","unstructured":"Rotz SJ, O\u2019Riordan MA, Kim C, de Lima M, Gladwin MT, Little JA. Traffic Light: prognosis-based eligibility for clinical trials of hematopoietic SCT in adults with sickle cell anemia. Bone Marrow Transplant. 2015;50:918\u201323.","journal-title":"Bone Marrow Transplant"},{"key":"111_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jama.2014.7192","volume":"312","author":"MM Hsieh","year":"2014","unstructured":"Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, et al. Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype. JAMA. 2014;312:48\u201356.","journal-title":"JAMA"},{"key":"111_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbmt.2015.12.002","volume":"22","author":"MM Hsieh","year":"2016","unstructured":"Hsieh MM. A standard nonmyeloablative transplantation regimen for adults with sickle cell disease: are we there yet? Biol Blood Marrow Transplant. 2016;22:397\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"111_CR20","first-page":"825","volume":"15","author":"D Przepiorka","year":"1995","unstructured":"Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant. 1995;15:825\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"111_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0002-9343(80)90380-0","volume":"69","author":"HM Shulman","year":"1980","unstructured":"Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204\u201317.","journal-title":"Am J Med"},{"key":"111_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, et al. Clinical manifestations of graft-versushost disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295\u2013304.","journal-title":"Transplantation"},{"key":"111_CR23","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1053\/bbmt.2003.50026","volume":"9","author":"SJ Lee","year":"2003","unstructured":"Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9:215\u201333.","journal-title":"Biol Blood Marrow Transplant"},{"key":"111_CR24","first-page":"102","volume":"12","author":"H Ko\u00e7yi\u011fit","year":"1999","unstructured":"Ko\u00e7yi\u011fit H, Aydemir \u00d6, \u00d6lmez N, Memi\u015f A. K\u0131sa Form-36 (KF-36)\u2018n\u0131n T\u00fcrk\u00e7e Versiyonunun G\u00fcvenilirli\u011fi ve Ge\u00e7erlili\u011fi. \u0130la\u00e7 ve Tedavi Derg. 1999;12:102\u20136.","journal-title":"\u0130la\u00e7 ve Tedavi Derg"},{"key":"111_CR25","unstructured":"Ware JE, Kosinski M, Keller S. SF-36 physical and mental health summary scales: a user\u2019s manual. Health Assessment Lab; 1994."},{"issue":"4 Suppl","key":"111_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.amepre.2009.12.022","volume":"38","author":"KL Hassell","year":"2010","unstructured":"Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38(4 Suppl):512\u201321.","journal-title":"Am J Prev Med"},{"key":"111_CR27","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1038\/bmt.2014.167","volume":"49","author":"G Lucarelli","year":"2014","unstructured":"Lucarelli G, Isgr\u00f2 A, Sodani P, Marziali M, Gaziev J, Paciaroni K, et al. Hematopoietic SCT for the Black African and non-Black African variants of sickle cell anemia. Bone Marrow Transplant. 2014;49:1376\u201381.","journal-title":"Bone Marrow Transplant"},{"key":"111_CR28","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1182\/blood-2013-03-489112","volume":"122","author":"F Locatelli","year":"2013","unstructured":"Locatelli F, Kabbara N, Ruggeri A, Ghavamzadeh A, Roberts I, Li CK, et al. Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood. 2013;122:1072\u20138.","journal-title":"Blood"},{"key":"111_CR29","doi-asserted-by":"publisher","first-page":"e0165833","DOI":"10.1371\/journal.pone.0165833","volume":"11","author":"LS Torres","year":"2016","unstructured":"Torres LS, Okumura JV, Silva DG, Mimura KK, Belini-J\u00fanior \u00c9, Oliveira RG, et al. Inflammation in sickle cell disease: differential and down-expressed plasma levels of annexin A1 protein. PLoS ONE. 2016;11:e0165833.","journal-title":"PLoS ONE"},{"key":"111_CR30","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S1083-8791(03)00192-7","volume":"9","author":"R Iannone","year":"2003","unstructured":"Iannone R, Casella JF, Fuchs EJ, Chen AR, Jones RJ, Woolfrey A, et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta thalassemia. Biol Blood Marrow Transplant. 2003;9:519\u201328.","journal-title":"Biol Blood Marrow Transplant"},{"key":"111_CR31","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1038\/bmt.2014.84","volume":"49","author":"M Bhatia","year":"2014","unstructured":"Bhatia M, Jin Z, Baker C, Geyer MB, Radhakrishnan K, Morris E, et al. Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease. Bone Marrow Transplant. 2014;49:913\u201320.","journal-title":"Bone Marrow Transplant"},{"key":"111_CR32","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1056\/NEJM200001133420203","volume":"342","author":"ST Miller","year":"2000","unstructured":"Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000;342:83\u201389.","journal-title":"N Engl J Med"},{"key":"111_CR33","doi-asserted-by":"publisher","first-page":"5300","DOI":"10.1182\/blood-2009-04-146852","volume":"115","author":"RE Ware","year":"2010","unstructured":"Ware RE. How I use hydroxyurea to treat young patients with sickle cell anemia. Blood. 2010;115:5300\u201311.","journal-title":"Blood"},{"key":"111_CR34","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/S0140-6736(11)60355-3","volume":"377","author":"WC Wang","year":"2011","unstructured":"Wang WC, Ware RE, Miller ST, Iyer RV, Casella JF, Minniti CP, et al. Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet. 2011;377:1663\u201372.","journal-title":"Lancet"},{"key":"111_CR35","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1111\/bjh.12737","volume":"165","author":"L Dedeken","year":"2014","unstructured":"Dedeken L, L\u00ea PQ, Azzi N, Brachet C, Heijmans C, Huybrechts S, et al. Haematopoietic stem cell transplantation for severe sickle cell disease in childhood: a single centre experience of 50 patients. Br J Haematol. 2014;165:402\u20138.","journal-title":"Br J Haematol"},{"key":"111_CR36","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.bbmt.2015.08.036","volume":"22","author":"SL Saraf","year":"2016","unstructured":"Saraf SL, Oh AL, Patel PR, Jalundhwala Y, Sweiss K, Koshy M, et al. Nonmyeloablative stem cell transplantation with alemtuzumab\/low-dose irradiation to cure and improve the quality of life of adults with sickle cell disease. Biol Blood Marrow Transplant. 2016;22:441\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"111_CR37","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1038\/sj.leu.2404683","volume":"21","author":"M Mohty","year":"2007","unstructured":"Mohty M. Mechanism of action of antithymocyte globulin: T-cell depletion and beyond. Leukemia. 2007;21:1387\u201394.","journal-title":"Leukemia"},{"key":"111_CR38","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1080\/17474086.2017.1318054","volume":"10","author":"A Mussetti","year":"2017","unstructured":"Mussetti A, Greco R, Peccatori J, Corradini P. Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand? Expert Rev Hematol. 2017;10:479\u201392.","journal-title":"Expert Rev Hematol"},{"key":"111_CR39","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.bbmt.2015.04.025","volume":"21","author":"N Cieri","year":"2015","unstructured":"Cieri N, Greco R, Crucitti L, Morelli M, Giglio F, Levati G, et al. Posttransplantation cyclophosphamide and sirolimus after haploidentical hematopoietic stem cell transplantation using a treosulfan-based myeloablative conditioning and peripheral blood stem cells. Biol Blood Marrow Transplant. 2015;21:1506\u201314.","journal-title":"Biol Blood Marrow Transplant"},{"key":"111_CR40","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.bbmt.2015.08.034","volume":"22","author":"E Jacoby","year":"2016","unstructured":"Jacoby E, Chen A, Loeb DM, Gamper CJ, Zambidis E, Llosa NJ, et al. Single-agent post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis after human leukocyte antigen-matched related bone marrow transplantation for pediatric and young adult patients with hematologic malignancies. Biol Blood Marrow Transplant. 2016;22:112\u20138.","journal-title":"Biol Blood Marrow Transplant"},{"key":"111_CR41","doi-asserted-by":"publisher","first-page":"4285","DOI":"10.1182\/blood-2012-07-438408","volume":"120","author":"J Bolanos-Meade","year":"2012","unstructured":"Bolanos-Meade J, Fuchs EJ, Luznik L, Lanskron SM, Gamper CS, Jones RJ, et al. HLA haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease. Blood. 2012;120:4285\u201391.","journal-title":"Blood"},{"key":"111_CR42","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/trf.13551","volume":"56","author":"SR Panch","year":"2016","unstructured":"Panch SR, Yau YY, Fitzhugh CD, Hsieh MM, Tisdale JF, Leitman SF. Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait. Transfusion. 2016;56:1058\u201365.","journal-title":"Transfusion"},{"key":"111_CR43","doi-asserted-by":"publisher","unstructured":"Gereklioglu C, Asma S, Korur A, Tepebas\u0131 S, Aytan P, Yeral M, et al. Granulocyte colony stimulated factor administration among hemoglobin S trait donors: a single center experience from the Eastern Meditteranean region. J Clin Apher. 2017. \n                    https:\/\/doi.org\/10.1002\/jca.21566\n                    \n                  .","DOI":"10.1002\/jca.21566"},{"key":"111_CR44","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/bjh.14167","volume":"174","author":"SD Arnold","year":"2016","unstructured":"Arnold SD, Bhatia M, Horan J, Krishnamurti L. Haematopoietic stem cell transplantation for sickle cell disease-current practice and new approaches. Br J Haematol. 2016;174:515\u201325.","journal-title":"Br J Haematol"},{"key":"111_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.bbmt.2009.10.005","volume":"16","author":"MC Walters","year":"2010","unstructured":"Walters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F, et al. Multicenter Study of Bone Marrow Transplantation for Sickle Cell Disease. Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. Biol Blood Marrow Transplant. 2010;16:263\u201372.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0111-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41409-018-0111-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:11:30Z","timestamp":1684617090000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-018-0111-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,5]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["111"],"URL":"https:\/\/doi.org\/10.1038\/s41409-018-0111-y","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,5]]},"assertion":[{"value":"29 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}